An ageing population brings new challenges both to healthcare systems and to medicine in terms of the increased manifestation of specific diseases primarily seen in the elderly. Biomedical innovation, and in particular research into "omics technologies", offers the promise of new means of detection, prevention and treatment of age-related disabilities and diseases.
This publication addresses the role of national systems of IP in the socio-economic development of emerging countries, notably through their impact on innovation. It presents a framework that identifies the key mechanisms that enable IP systems to support emerging countries’ innovation and development objectives.
English, PDF, 3,023kb
In very simple terms, smart specialisation suggests that countries or regions should identify and select a limited number of priority areas for knowledge-based investments, focusing on strengths and comparative advantages. This report uses case studies to illustrate how smart specialisation can be used to design better public policies for boosting innovation-driven growth in OECD regions. It also examines governance and evaluation.
This report describes recent trends in government and institutional level policies to enhance the transfer and exploitation of public research. It also benchmarks a set of countries, universities and public research institutions based on both traditional and new indicators.
This paper presents the findings of a survey of 25 countries. It provides a snapshot of current national or regional policy and research programmes designed to stimulate the growth of nanotechnology applications in diverse sectors of the economy while addressing the potential risks and the ethical and social challenges the technology might raise.
This new document is available as a tool for environmental safety assessment of new varieties of sugarcane derived from modern biotechnology. Given the large production of this crop worldwide, its biosafety will be an important issue for many countries.
This paper explores the development of the bioplastics sector and its role in national bioeconomy strategies. It finds that bioplastics are at a disadvantage compared to some other biobased products, notably biofuels, that often benefit from preferential treatment. It also notes that greater efforts are needed at the international level as regards standards to avoid creating barriers to international trade in biobased products.
The STI Scoreboard analyses the major trends in knowledge and innovation in today’s global economy. With over 250 indicators it presents a policy-oriented review of science, technology, innovation and industrial performance in OECD and major non-OECD economies.
In many OECD countries, investment in intangible assets is growing rapidly. In some cases this investment matches or exceeds investment in traditional capital such as machinery, equipment and buildings.
English, PDF, 1,992kb
Governments have a fiscal and social responsibility to ensure that limited research and development resources are used wisely and cost-effectively in support of social, economic, and scientific aspirations. Countries that wish to promote the continued responsible development of nanotechnology will, however, need quantitative data on the economic impact of nanotechnology to guide further investment and policy decisions.